Previous studies revealed that EMT is commonly overactive in HCC and through its role in GSK-3β phosphonation and downstream impact on β-catenin (Galluzzi et al., 2019; Duda et al., 2020). The gene discussed is GSK3B; the disease is hepatocellular carcinoma.